Breaking News Instant updates and real-time market news.

2020-10-12 08:24:45 DJX Dow Jones Industrial Average $0.00 / + (+0.00%) 08:24 10/12/20 10/12 08:24 10/12/20 08:24	Dow Jones Industrial Average: Pivot points The following are the pivot points for the Dow Jones Industrial Average (DJX). Pivot High: 28749.425, Pivot Low: 28513.765. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.
DJX Dow Jones Industrial Average $0.00 / + (+0.00%) 02/27/20 Keefe Bruyette Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says 02/24/20 Dow Jones futures decline over 800 points ahead of today's open

2020-10-12 08:24:45

DJX

Dow Jones Industrial Average

$0.00 / + (+0.00%)

08:24

10/12/20

10/12

08:24

10/12/20

08:24

Dow Jones Industrial Average: Pivot points

The following are the pivot points for the Dow Jones Industrial Average (DJX). Pivot High: 28749.425, Pivot Low: 28513.765. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

DJX Dow Jones Industrial Average

$0.00 / + (+0.00%)

02/27/20 Keefe Bruyette: Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says

02/24/20: Dow Jones futures decline over 800 points ahead of today's open

TODAY'S FREE FLY STORIES

Downgrade	Pacific Basin Shipping downgraded to Hold from Buy at Jefferies » 07:41 03/03/21 03/03 07:41 03/03/21 07:41 PCFBF Pacific Basin Shipping $0.00 / + (+0.00%) Jefferies analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PCFBF Pacific Basin Shipping $0.00 / + (+0.00%) 06/25/20 JPMorgan Pacific Basin Shipping downgraded to Neutral from Overweight at JPMorgan
Recommendations	Kopin price target raised to $12 from $5.50 at Ladenburg » 07:40 03/03/21 03/03 07:40 03/03/21 07:40 KOPN Kopin $9.92 / +0.78 (+8.53%) Ladenburg analyst Glenn… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options KOPN Kopin $9.92 / +0.78 (+8.53%) 02/23/21 Kopin director Collins sells almost $2M in company shares 02/23/21 Kopin trading resumes 02/23/21 Kopin trading halted, volatility trading pause 02/02/21 Kopin, HMDmd in development pact for wearable display system for surgeons KOPN Kopin $9.92 / +0.78 (+8.53%) 06:09 Today H.C. Wainwright Kopin downgraded to Neutral from Buy at H.C. Wainwright 01/11/21 H.C. Wainwright Kopin price target raised to $3.50 from $2 at H.C. Wainwright 08/25/20 Fly Intel: Top five analyst initiations 08/25/20 H.C. Wainwright Kopin initiated with a Buy at H.C. Wainwright KOPN Kopin $9.92 / +0.78 (+8.53%) 11/03/20 Kopin reports Q3 EPS (1c), consensus (2c) KOPN Kopin $9.92 / +0.78 (+8.53%) 03/02/21 Unusually active option classes on open March 2nd
Initiation	CuriosityStream initiated with a Buy at Needham » 07:39 03/03/21 03/03 07:39 03/03/21 07:39 CURI CuriosityStream $18.66 / -0.18 (-0.96%) Needham analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events Options CURI CuriosityStream $18.66 / -0.18 (-0.96%) 10/14/20 CuriosityStream to begin trading on Nasdaq with ticker 'CURI' after closing deal CURI CuriosityStream $18.66 / -0.18 (-0.96%) 06:28 Today Needham CuriosityStream initiated with a Buy at Needham 02/16/21 Fly Intel: Top five analyst initiations 02/16/21 Roth Capital CuriosityStream initiated with a Buy at Roth Capital 01/12/21 Benchmark CuriosityStream initiated with a Buy at Benchmark 04 Feb CURI CuriosityStream $18.66 / -0.18 (-0.96%) 02/01/21 Fly Intel: After-Hours Movers 01/06/21 Fly Intel: Pre-market Movers 03/23/21 CuriosityStream - CURI CURI CuriosityStream $18.66 / -0.18 (-0.96%) 01/21/21 Eighteen new option listings and one option delisting on January 21st
Initiation	Gemini Therapeutics initiated with a Buy at Jefferies » 07:39 03/03/21 03/03 07:39 03/03/21 07:39 GMTX Gemini Therapeutics $16.05 / +0.46 (+2.95%) Jefferies analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options GMTX Gemini Therapeutics $16.05 / +0.46 (+2.95%) 02/10/21 Gemini Therapeutics completes enrollment in Phase 2a Trial of GEM103 02/09/21 Gemini Therapeutics appoints Brian Piekos as CFO 02/08/21 Gemini Therapeutics completes business combination with FSDC, debuts on Nasdaq GMTX Gemini Therapeutics $16.05 / +0.46 (+2.95%) 03/02/21 Goldman Sachs Gemini Therapeutics initiated with a Buy at Goldman Sachs 02/16/21 Stifel Gemini Therapeutics initiated with a Buy at Stifel GMTX Gemini Therapeutics $16.05 / +0.46 (+2.95%) 02/09/21 Five new option listings and two option delistings on February 9th
Hot Stocks	Kaleido Biosciences announces anticipated near-term milestones » 07:38 03/03/21 03/03 07:38 03/03/21 07:38 KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) Anticipated Near-Term… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 07:38 Today Kaleido Biosciences sees cash runway into 1Q22 01/14/21 Kaleido Biosciences announces interim results of controlled study of KB109 01/04/21 Kaleido Biosciences completes enrollment of 350 subjects in KB109 study 11/02/20 Kaleido Biosciences sees cash runway into 2H21 KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 02/09/21 Piper Sandler Kaleido Biosciences initiated with an Overweight at Piper Sandler 01/14/21 Chardan Kaleido Biosciences price target raised to $17.50 from $10 at Chardan 12/23/20 JMP Securities Kaleido Biosciences initiated with an Outperform at JMP Securities 10/14/20 JPMorgan Kaleido Biosciences resumed with an Underweight at JPMorgan KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 07:37 Today Kaleido Biosciences reports Q4 EPS (56c), consensus (40c) 11/02/20 Kaleido Biosciences reports Q3 EPS (65c), consensus (63c) 04 Feb 02 Jun 03/17/21 Kaleido Biosciences - KLDO 03/19/21 Kaleido Biosciences KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/28/21 new option listings on January 28th

Hot Stocks	Dollar Tree sees FY21 store openings of 600 » 07:38 03/03/21 03/03 07:38 03/03/21 07:38 DLTR Dollar Tree $99.03 / -0.16 (-0.16%) For FY21, the company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/16/21 SPAR Group appoints Mike Matacunas as president, CEO 02/04/21 Instacart announces new national delivery partnership with Family Dollar 12/07/20 Dollar Tree CEO sells 12.4K shares of common stock 12/03/20 Dollar Tree Director Thomas Saunders sells almost $12M in company shares DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/25/21 Fly Intel: Pre-market Movers 02/25/21 BofA BofA double downgrades Dollar Tree to Underperform, sees multiple headwinds 02/25/21 BofA Dollar Tree downgraded to Underperform from Buy at BofA 02/16/21 JPMorgan Dollar Tree price target raised to $134 from $130 at JPMorgan DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 07:36 Today Dollar Tree reports Q4 EPS $2.13, consensus $2.11 11/24/20 Dollar Tree reports Q3 EPS $1.39, consensus $1.15 11/23/20 Notable companies reporting before tomorrow's open 11/23/20 Notable companies reporting before tomorrow's open DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 11/24/20 Fly Intel: Wall Street's top stories for Tuesday 11/24/20 Fly Intel: Wall Street's top stories at midday 11/24/20 Fly Intel: Pre-market Movers 09:00 Today Dollar Tree - DLTR DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 12/16/20 Early notable gainers among liquid option names on December 16th 11/24/20 Early notable gainers among liquid option names on November 24th 10/23/20 Dollar Tree call volume above normal and directionally bullish
Hot Stocks	Kaleido Biosciences sees cash runway into 1Q22 » 07:38 03/03/21 03/03 07:38 03/03/21 07:38 KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) As of December 31, 2020,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/14/21 Kaleido Biosciences announces interim results of controlled study of KB109 01/04/21 Kaleido Biosciences completes enrollment of 350 subjects in KB109 study 11/02/20 Kaleido Biosciences sees cash runway into 2H21 11/02/20 Kaleido Biosciences announces anticipated milestones KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 02/09/21 Piper Sandler Kaleido Biosciences initiated with an Overweight at Piper Sandler 01/14/21 Chardan Kaleido Biosciences price target raised to $17.50 from $10 at Chardan 12/23/20 JMP Securities Kaleido Biosciences initiated with an Outperform at JMP Securities 10/14/20 JPMorgan Kaleido Biosciences resumed with an Underweight at JPMorgan KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 07:37 Today Kaleido Biosciences reports Q4 EPS (56c), consensus (40c) 11/02/20 Kaleido Biosciences reports Q3 EPS (65c), consensus (63c) 04 Feb 02 Jun 03/17/21 Kaleido Biosciences - KLDO 03/19/21 Kaleido Biosciences KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/28/21 new option listings on January 28th
Hot Stocks	Tradeweb Markets reports February total trading volume $20.4T » 07:37 03/03/21 03/03 07:37 03/03/21 07:37 TW Tradeweb Markets $73.33 / -0.44 (-0.60%) Tradeweb Markets reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events TW Tradeweb Markets $73.33 / -0.44 (-0.60%) 02/04/21 Tradeweb Markets reports $20T total volume traded in January 02/04/21 Tradeweb Markets sees FY21 CapEx $45M-$50M 02/02/21 Tradeweb Markets to acquire Nasdaq fixed income trade platform for $190M 02/02/21 Nasdaq to sell U.S. fixed income business to Tradeweb Markets TW Tradeweb Markets $73.33 / -0.44 (-0.60%) 03/02/21 Morgan Stanley Tradeweb Markets resumed with an Overweight at Morgan Stanley 02/22/21 Goldman Sachs Tradeweb Markets upgraded to Buy from Neutral at Goldman Sachs 01/13/21 Compass Point Tradeweb Markets upgraded in relative call against MarketAxess at Compass Point 01/13/21 Compass Point Tradeweb Markets upgraded to Buy from Neutral at Compass Point TW Tradeweb Markets $73.33 / -0.44 (-0.60%) 02/04/21 Tradeweb Markets reports Q4 adjusted EPS 34c, consensus 34c 10/28/20 Tradeweb Markets reports Q3 EPS 30c, consensus 29c 23 Apr 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 04/29/21 Tradeweb Markets - TW
Earnings	Kaleido Biosciences reports Q4 EPS (56c), consensus (40c) » 07:37 03/03/21 03/03 07:37 03/03/21 07:37 KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/14/21 Kaleido Biosciences announces interim results of controlled study of KB109 01/04/21 Kaleido Biosciences completes enrollment of 350 subjects in KB109 study 11/02/20 Kaleido Biosciences sees cash runway into 2H21 11/02/20 Kaleido Biosciences announces anticipated milestones KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 02/09/21 Piper Sandler Kaleido Biosciences initiated with an Overweight at Piper Sandler 01/14/21 Chardan Kaleido Biosciences price target raised to $17.50 from $10 at Chardan 12/23/20 JMP Securities Kaleido Biosciences initiated with an Outperform at JMP Securities 10/14/20 JPMorgan Kaleido Biosciences resumed with an Underweight at JPMorgan KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 11/02/20 Kaleido Biosciences reports Q3 EPS (65c), consensus (63c) 04 Feb 02 Jun 03/17/21 Kaleido Biosciences - KLDO 03/19/21 Kaleido Biosciences KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/28/21 new option listings on January 28th
Options	Unusual call flow in option market yesterday » 07:36 03/03/21 03/03 07:36 03/03/21 07:36 RKT Rocket Companies $41.70 / +17.4 (+71.60%) , NLS Nautilus $20.46 / +1.27 (+6.62%) Notable call activity was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 03/02/21 Rocket Companies soars as short interest gets highlighted 03/02/21 Rocket resumes trading after volatility halt, shares up 57% to $38.07 03/02/21 Rocket Companies trading resumes 03/02/21 Rocket Companies trading halted, volatility trading pause NLS Nautilus $20.46 / +1.27 (+6.62%) 02/23/21 Nautilus falls -20.6% 02/22/21 Nautilus drops 8% to $24.50 after Q4 revenue misses consensus 02/22/21 Nautilus says demand for in-home fitness has not abated in 2021 12/30/20 Nautilus to change fiscal year to start in April and end in March RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 06:34 Today Zelman Rocket Companies downgraded to Hold from Buy at Zelman 03/02/21 RBC Capital Rocket Companies downgraded to Sector Perform from Outperform at RBC Capital 03/02/21 Wells Fargo Wells says Rocket Companies Q4 results 'not good enough to support' today's move 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance NLS Nautilus $20.46 / +1.27 (+6.62%) 11/10/20 Lake Street Nautilus price target raised to $40 from $30 at Lake Street 11/10/20 Craig-Hallum Nautilus price target raised to $28 from $22 at Craig-Hallum 10/15/20 Lake Street Nautilus price target raised to $30 from $17 at Lake Street 10/14/20 Truist Nautilus price target raised to $28 from $18 at Truist RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 NLS Nautilus $20.46 / +1.27 (+6.62%) 02/22/21 Nautilus sees Q1 net sales growth of 55%-75% over last year 02/22/21 Nautilus reports Q4 EPS 89c, consensus 75c 11/09/20 Nautilus sees FY20 revenue $540M-$565M, consensus $448.61M 11/09/20 Nautilus reports Q3 adjusted EPS 87c, consensus 32c 06 Aug RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports NLS Nautilus $20.46 / +1.27 (+6.62%) 11/25/20 Peloton shipping delays may benefit Nautilus, WSJ reports 10/05/20 NordicTrack owner valued at over $7B in new funding round, Bloomberg says 09/09/20 Citron sets $30 target on Nautilus, predicts earnings 'blow out' RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers NLS Nautilus $20.46 / +1.27 (+6.62%) 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 Fly Intel: Pre-market Movers 02/22/21 Fly Intel: After-Hours Movers RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 03/02/21 Callapalozza in Rocket Mortage echoes Gamestop squeeze 03/02/21 Unusually active option classes on open March 2nd 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st NLS Nautilus $20.46 / +1.27 (+6.62%) 03/02/21 Aggressive buyer sweeps October calls in Nautilus 11/09/20 Nautilus options imply 29.0% move in share price post-earnings 09/21/20 Nautilus call volume above normal and directionally bullish 09/09/20 Unusually active option classes on open September 9th

Earnings	Dollar Tree reports Q4 EPS $2.13, consensus $2.11 » 07:36 03/03/21 03/03 07:36 03/03/21 07:36 DLTR Dollar Tree $99.03 / -0.16 (-0.16%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/16/21 SPAR Group appoints Mike Matacunas as president, CEO 02/04/21 Instacart announces new national delivery partnership with Family Dollar 12/07/20 Dollar Tree CEO sells 12.4K shares of common stock 12/03/20 Dollar Tree Director Thomas Saunders sells almost $12M in company shares DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/25/21 Fly Intel: Pre-market Movers 02/25/21 BofA BofA double downgrades Dollar Tree to Underperform, sees multiple headwinds 02/25/21 BofA Dollar Tree downgraded to Underperform from Buy at BofA 02/16/21 JPMorgan Dollar Tree price target raised to $134 from $130 at JPMorgan DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 11/24/20 Dollar Tree reports Q3 EPS $1.39, consensus $1.15 11/23/20 Notable companies reporting before tomorrow's open 11/23/20 Notable companies reporting before tomorrow's open DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 11/24/20 Fly Intel: Wall Street's top stories for Tuesday 11/24/20 Fly Intel: Wall Street's top stories at midday 11/24/20 Fly Intel: Pre-market Movers 09:00 Today Dollar Tree - DLTR DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 12/16/20 Early notable gainers among liquid option names on December 16th 11/24/20 Early notable gainers among liquid option names on November 24th 10/23/20 Dollar Tree call volume above normal and directionally bullish
Recommendations	Arena Pharmaceuticals price target lowered to $100 from $106 at Cantor Fitzgerald » 07:35 03/03/21 03/03 07:35 03/03/21 07:35 ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) Cantor Fitzgerald analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 03/02/21 Arena Pharmaceuticals slides after IBS trial did not meet primary endpoint 03/02/21 Arena Pharmaceuticals reports topline results from Phase 2b CAPTIVATE trial 02/02/21 Arena Pharmaceuticals completes enrollment of ELEVATE UC 52 trial 12/08/20 Arena Pharmaceuticals achieves target enrollment for Phase 3 ELEVATE UC 52 trial ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 05:03 Today JonesTrading Arena Pharmaceuticals price target lowered to $94 from $101 at JonesTrading 01/28/21 JonesTrading Arena Pharmaceuticals initiated with a Buy at JonesTrading 11/19/20 SMBC Nikko Arena Pharmaceuticals initiated with an Outperform at SMBC Nikko 11/10/20 RBC Capital Arena Pharmaceuticals price target lowered to $76 from $80 at RBC Capital ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 02/23/21 Arena Pharmaceuticals reports Q4 EPS ($2.10), consensus ($1.85) 11/09/20 Arena Pharmaceuticals reports Q3 EPS ($1.69), consensus ($1.87) 28 May ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 11/05/20 Governor Cuomo says NY 'ripe' for pot legalization, amNewYork says 11/04/20 Marijuana legalization measures set to pass in five states, Tech Crunch says ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 03/02/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: Wall Street's top stories for Tuesday 11/10/20 Fly Intel: Wall Street's top stories at midday 11/10/20 Fly Intel: Pre-market Movers
Hot Stocks	Strongbridge Biopharma sees 2021 KEVEYIS revenue $34M-$36M » 07:34 03/03/21 03/03 07:34 03/03/21 07:34 SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) Revenue consensus… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 07:33 Today Strongbridge Biopharma expects cash to fund operations into 1Q23 07:33 Today Strongbridge Biopharma reports Q4 EPS (11c), consensus (12c) 03/02/21 Strongbridge Biopharma submits NDA for RECORLEV 02/16/21 iBio appoints Robert Lutz as CFO and CBO SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/08/20 JMP Securities Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities 03/03/20 Fly Intel: Top five analyst initiations 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 01/06/21 Strongbridge Biopharma sees 2021 KEVEYIS revenue approx. $34M-$36M 01/06/21 Strongbridge Biopharma sees 2020 KEVEYIS revenue approx. $30.7M 01/06/21 Strongbridge Biopharma sees Q4 KEVEYIS revenue approx. $8.2M 10/29/20 Strongbridge Biopharma reports Q3 EPS (18c), consensus (13c) 17 Sep SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/17/20 Fly Intel: Pre-market Movers 09/16/20 Fly Intel: After-Hours Movers 03/16/21 31st Annual Healthcare Virtual Conference 08:30 Today Strongbridge Biopharma - SBBP
Hot Stocks	Ituran to distribute 48c per share cash dividend » 07:34 03/03/21 03/03 07:34 03/03/21 07:34 ITRN Ituran $21.44 / -0.64 (-2.90%) Ituran announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events ITRN Ituran $21.44 / -0.64 (-2.90%) 07/21/20 Jefferies Ituran downgraded to Hold on South America exposure at Jefferies 07/21/20 Jefferies Ituran downgraded to Hold from Buy at Jefferies 09:00 Today Ituran - ITRN
Hot Stocks	Jones Lang LaSalle launches commercial partnership, investment in Roofstock » 07:34 03/03/21 03/03 07:34 03/03/21 07:34 JLL Jones Lang LaSalle $178.34 / -0.7 (-0.39%) JLL announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events JLL Jones Lang LaSalle $178.34 / -0.7 (-0.39%) 02/17/21 JLL appoints Gilda Perez-Alvarado as global CEO, Hotels & Hospitality 01/25/21 JLL appoints Ingrid Jacobs as head of diversity, inclusion 11/24/20 BP, Jones Lang LaSalle enter multi-year vested workplace evolution agreement 11/20/20 JLL names Rastogi chief product officer to lead JLL Technologies JLL Jones Lang LaSalle $178.34 / -0.7 (-0.39%) 02/26/21 JPMorgan Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan 01/25/21 Goldman Sachs Jones Lang LaSalle initiated with a Buy at Goldman Sachs 12/21/20 JPMorgan Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan 10/07/20 Keefe Bruyette Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette JLL Jones Lang LaSalle $178.34 / -0.7 (-0.39%) 02/09/21 Jones Lang LaSalle reports Q4 adjusted EPS $5.29 vs. $6.35 a year ago 02/09/21 Jones Lang LaSalle reports Q4 adjusted EPS $5.29, consensus $3.93 11/02/20 Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25 11/02/20 Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25 10:00 Today Jones Lang LaSalle - JLL

Hot Stocks	Strongbridge Biopharma expects cash to fund operations into 1Q23 » 07:33 03/03/21 03/03 07:33 03/03/21 07:33 SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) Assuming the availability… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 07:33 Today Strongbridge Biopharma reports Q4 EPS (11c), consensus (12c) 03/02/21 Strongbridge Biopharma submits NDA for RECORLEV 02/16/21 iBio appoints Robert Lutz as CFO and CBO 02/16/21 Strongbridge Biopharma appoints Richard Kollender as president, CFO SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/08/20 JMP Securities Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities 03/03/20 Fly Intel: Top five analyst initiations 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 01/06/21 Strongbridge Biopharma sees 2021 KEVEYIS revenue approx. $34M-$36M 01/06/21 Strongbridge Biopharma sees 2020 KEVEYIS revenue approx. $30.7M 01/06/21 Strongbridge Biopharma sees Q4 KEVEYIS revenue approx. $8.2M 10/29/20 Strongbridge Biopharma reports Q3 EPS (18c), consensus (13c) 17 Sep SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/17/20 Fly Intel: Pre-market Movers 09/16/20 Fly Intel: After-Hours Movers 03/16/21 31st Annual Healthcare Virtual Conference 08:30 Today Strongbridge Biopharma - SBBP
Recommendations	HP Enterprise price target raised to $20 from $17 at BofA » 07:33 03/03/21 03/03 07:33 03/03/21 07:33 HPE HP Enterprise $14.51 / -0.105 (-0.72%) BofA analyst Wamsi Mohan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HPE HP Enterprise $14.51 / -0.105 (-0.72%) 01/27/21 HP Enterprise to build $35M+ supercomputer for NCAR 12/08/20 Verizon expands SD WAN portfolio with Silver Peak 12/01/20 HP Enterprise to relocate headquarters to Houston, Texas 11/17/20 Zuora announces Paul Heard as chief information officer HPE HP Enterprise $14.51 / -0.105 (-0.72%) 01/15/21 Fly Intel: Top five analyst upgrades 01/15/21 JPMorgan JPMorgan upgrades 'good contrarian long trade' HP Enterprise to Overweight 01/15/21 JPMorgan HP Enterprise upgraded to Overweight from Neutral at JPMorgan 12/16/20 Morgan Stanley HP Enterprise price target raised to $13.50 from $13 at Morgan Stanley HPE HP Enterprise $14.51 / -0.105 (-0.72%) 03/02/21 HP Enterprise raises FY21 adjusted EPS view to $1.70-$1.88, consensus $1.67 03/02/21 HP Enterprise sees Q2 adjusted EPS 38c-44c, consensus 38c 03/02/21 HP Enterprise reports Q1 adjusted EPS 52c, consensus 41c 12/01/20 HP Enterprise sees Q1 revenue down mid-single digits from Q4 HPE HP Enterprise $14.51 / -0.105 (-0.72%) 12/02/20 Fly Intel: Wall Street's top stories for Wednesday 12/02/20 Fly Intel: Wall Street's top stories at midday 12/01/20 Fly Intel: After-Hours Movers 10/16/20 Fly Intel: Wall Street's top stories for Friday 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 04/14/21 Hewlett Packard Enterprise Co. HPE HP Enterprise $14.51 / -0.105 (-0.72%) 12/01/20 Hewlett Packard Enterprise options imply 9.8% move in share price post-earnings 11/10/20 Hewlett Packard Enterprise put volume heavy and directionally bearish 10/14/20 Hewlett Packard Enterprise call volume above normal and directionally bullish 09/29/20 Hewlett Packard Enterprise put volume heavy and directionally bearish
Hot Stocks	Strongbridge Biopharma reports Q4 EPS (11c), consensus (12c) » 07:33 03/03/21 03/03 07:33 03/03/21 07:33 SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) Reports Q4 revenue $8.2M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 03/02/21 Strongbridge Biopharma submits NDA for RECORLEV 02/16/21 iBio appoints Robert Lutz as CFO and CBO 02/16/21 Strongbridge Biopharma appoints Richard Kollender as president, CFO 02/03/21 Strongbridge Biopharma announces employment inducement awards SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/08/20 JMP Securities Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities 03/03/20 Fly Intel: Top five analyst initiations 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 01/06/21 Strongbridge Biopharma sees 2021 KEVEYIS revenue approx. $34M-$36M 01/06/21 Strongbridge Biopharma sees 2020 KEVEYIS revenue approx. $30.7M 01/06/21 Strongbridge Biopharma sees Q4 KEVEYIS revenue approx. $8.2M 10/29/20 Strongbridge Biopharma reports Q3 EPS (18c), consensus (13c) 17 Sep SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/17/20 Fly Intel: Pre-market Movers 09/16/20 Fly Intel: After-Hours Movers 03/16/21 31st Annual Healthcare Virtual Conference 08:30 Today Strongbridge Biopharma - SBBP
Recommendations	Kohl's price target raised to $67 from $65 at Cowen » 07:32 03/03/21 03/03 07:32 03/03/21 07:32 KSS Kohl's $57.36 / +0.41 (+0.72%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Kohl's planning $200M-$300M in share repurchases in 2021 03/02/21 Kohl's plans to refresh approximately 675 stores over the next two years 03/02/21 Kohl's 'optimistic that brighter days are ahead' 03/02/21 Kohl's 'confident' in ability to expand operating margin to 7%-8% by 2023 KSS Kohl's $57.36 / +0.41 (+0.72%) 06:37 Today Citi Kohl's price target raised to $67 from $56 at Citi 02/18/21 Morgan Stanley Kohl's price target raised to $40 from $27 at Morgan Stanley 02/05/21 Baird Kohl's price target raised to $58 from $48 at Baird 02/05/21 Deutsche Bank Kohl's price target raised to $55 from $51 at Deutsche Bank KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Kohl's sees FY21 EPS $2.45-$2.95, consensus ($2.43) 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 02/04/21 Kohl's reports preliminary Q4 EPS $1.00-$1.05, consensus 70c KSS Kohl's $57.36 / +0.41 (+0.72%) 02/22/21 Kohl's 'rejects' activist investor group attempt in statement to CNBC 02/21/21 Nine directors nominated to Kohl's board by activist investors, WSJ reports 09/21/20 Walmart to launch private label for men's and women's clothing, CNBC reports KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Pre-market Movers 02/22/21 Fly Intel: Wall Street's top stories for Monday KSS Kohl's $57.36 / +0.41 (+0.72%) 01/11/21 Early notable gainers among liquid option names on January 11th 12/30/20 Early notable gainers among liquid option names on December 30th 12/18/20 Early notable gainers among liquid option names on December 18th 12/11/20 Kohl's put volume heavy and directionally bearish
Recommendations	Dine Brands price target raised to $90 from $85 at Raymond James » 07:32 03/03/21 03/03 07:32 03/03/21 07:32 DIN Dine Brands $78.83 / -2.795 (-3.42%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings DIN Dine Brands $78.83 / -2.795 (-3.42%) 03/02/21 Dine Brands says Applebee's SSS improving roughly 8% QTD from January 03/02/21 Dine Brands sees FY21 capital expenditures $14M 11/17/20 Dine Brands names John Peyton, president and CEO DIN Dine Brands $78.83 / -2.795 (-3.42%) 07:08 Today Barclays Dine Brands price target raised to $95 from $80 at Barclays 02/10/21 Deutsche Bank Dine Brands downgraded to Hold from Buy at Deutsche Bank 01/20/21 Wedbush Dine Brands added to Best List Ideas, target raised to $83 at Wedbush 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James DIN Dine Brands $78.83 / -2.795 (-3.42%) 03/02/21 Dine Brands reports Q4 adjusted EPS 39c, consensus 67c 10/28/20 Dine Brands reports Q3 EPS 80c, consensus 36c

Hot Stocks	Dish, DraftKings announce strategic agreement » 07:32 03/03/21 03/03 07:32 03/03/21 07:32 DISH Dish $33.11 / +0.26 (+0.79%) , DKNG DraftKings $68.56 / -0.14 (-0.20%) DISH Network (DISH) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/23/21 ADT Inc., Dish partner to bring smart home security to more customers 02/22/21 Dish signs master lease agreement with SBA Communications 02/16/21 Dish announces seven new tower agreements 02/08/21 Dish selects Aviat Networks for 5G microwave wireless transport DKNG DraftKings $68.56 / -0.14 (-0.20%) 02/26/21 DraftKings MUPs for B2C segment up 44% vs. 4Q19 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/25/21 DraftKings names Cal Ripken Jr. as special advisor to board of directors DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/25/21 Oppenheimer Verizon, AT&T downgraded to Perform on valuation at Oppenheimer 02/23/21 Fly Intel: Top five analyst downgrades 02/23/21 Pivotal Research Dish downgraded to Hold from Buy at Pivotal Research 12/04/20 Guggenheim Dish downgraded to Neutral from Buy at Guggenheim DKNG DraftKings $68.56 / -0.14 (-0.20%) 03/01/21 Craig-Hallum DraftKings price target raised to $70 from $65 at Craig-Hallum 03/01/21 Canaccord DraftKings price target raised to $80 from $65 at Canaccord 03/01/21 Northland DraftKings price target raised to $70 from $55 at Northland 03/01/21 Benchmark DraftKings price target raised to $69 from $66 at Benchmark DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/22/21 Dish reports Q4 EPS $1.24, consensus 75c 11/06/20 Dish reports Q3 EPS 86c, consensus 70c DKNG DraftKings $68.56 / -0.14 (-0.20%) 02/26/21 DraftKings raises 2021 revenue view to $900M-$1B from $750M-$850M 02/26/21 DraftKings reports Q4 revenue $322M, consensus $232.6M 02/25/21 Notable companies reporting before tomorrow's open 02/25/21 Notable companies reporting before tomorrow's open 07 Oct 19 Jun DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 11/18/20 Dish 'improperly' received $3.3B in spectrum discounts, FBN says 11/02/20 Dish offers services to DoD's proposed 5G network project, WSJ reports 10/15/20 Dish, DirecTV merger again squashed by DOJ, NY Post reports 10/06/20 AT&T's auction of DirecTV turning into a 'fire sale," NY Post says DKNG DraftKings $68.56 / -0.14 (-0.20%) 03/02/21 Hedgeye adds DraftKings as a Best Idea Short 03/02/21 Connecticut, Mohegan Tribe reach deal on sports betting, The Day reports 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/25/21 Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 02/23/21 Starbucks upgrade, Kroger downgrade among today's top calls on Wall Street 02/22/21 Fly Intel: Pre-market Movers DKNG DraftKings $68.56 / -0.14 (-0.20%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/26/21 Fly Intel: Wall Street's top stories at midday 03/09/21 DraftKings Inc DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/25/21 Early notable gainers among liquid option names on February 25th 02/04/21 Dish Network put volume heavy and directionally bearish 12/22/20 Unusual call flow in option market yesterday 12/21/20 Dish Network put volume heavy and directionally bearish DKNG DraftKings $68.56 / -0.14 (-0.20%) 02/02/21 DraftKings call volume above normal and directionally bullish 01/27/21 DraftKings call volume above normal and directionally bullish 01/26/21 DraftKings call volume above normal and directionally bullish 01/12/21 DraftKings call volume above normal and directionally bullish
Downgrade	BankUnited downgraded to Neutral from Buy at Janney Montgomery Scott » 07:31 03/03/21 03/03 07:31 03/03/21 07:31 BKU BankUnited $42.03 / -0.025 (-0.06%) Janney Montgomery Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings BKU BankUnited $42.03 / -0.025 (-0.06%) 02/19/21 DA Davidson BankUnited downgraded to Neutral from Buy at DA Davidson 02/19/21 DA Davidson BankUnited downgraded to Neutral from Buy at DA Davidson 01/25/21 RBC Capital BankUnited price target raised to $42 from $39 at RBC Capital 01/08/21 UBS BankUnited downgraded to Neutral from Buy at UBS BKU BankUnited $42.03 / -0.025 (-0.06%) 01/21/21 BankUnited reports Q4 EPS 89c, consensus 70c 10/28/20 BankUnited reports Q3 EPS 70c, consensus 63c
Upgrade	Itron upgraded to Buy from Hold at Argus » 07:29 03/03/21 03/03 07:29 03/03/21 07:29 ITRI Itron $117.75 / -0.06 (-0.05%) Argus analyst John Eade… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ITRI Itron $117.75 / -0.06 (-0.05%) 02/17/21 Bsquare, Itron extend pact over industrial IoT innovation 01/19/21 Itron and Versant Power collaborate to modernize electricity grid in Maine 10/05/20 ON Semiconductor appoints Itron CEO Thomas Deitrich to board 10/05/20 Itron, Con Ed confirm, NYS affirmed its consent approval for Itron ERT module ITRI Itron $117.75 / -0.06 (-0.05%) 07:19 Today Argus Itron upgraded to Buy from Hold at Argus 02/25/21 Oppenheimer Itron price target raised to $127 from $75 at Oppenheimer 01/08/21 Raymond James Itron downgraded to Outperform from Strong Buy at Raymond James 01/08/21 Raymond James Itron downgraded to Outperform from Strong Buy at Raymond James ITRI Itron $117.75 / -0.06 (-0.05%) 02/24/21 Itron sees FY21 EPS $2.15-$2.55, consensus $2.26 02/24/21 Itron reports Q4 EPS 65c, consensus 30c 11/02/20 Itron reports Q3 EPS 61c, consensus 25c 03/08/21 Itron
Recommendations	Otis Worldwide price target raised to $77 from $75 at Cowen » 07:29 03/03/21 03/03 07:29 03/03/21 07:29 OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) Cowen analyst Cai Von… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) 02/10/21 Otis Worldwide selected to supply elevators, escalators in three Canadian cities 01/11/21 Otis Worldwide recommends shareholders reject TRC Capital 'mini-tender' offer 01/11/21 CVS Health names Laurie Havanec as Chief People Officer OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) 10/07/20 JPMorgan Otis Worldwide price target raised to $79 from $75 at JPMorgan 09/24/20 Wolfe Research Otis Worldwide upgraded to Outperform from Peer Perform at Wolfe Research 09/24/20 JPMorgan Otis Worldwide pullback due to 'unwarranted concerns,' says JPMorgan 07/29/20 Credit Suisse Otis Worldwide price target raised to $66 from $55 at Credit Suisse OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) 02/01/21 Otis Worldwide sees FY21 adjusted EPS $2.67-$2.77, consensus $2.62 02/01/21 Otis Worldwide reports Q4 non-GAAP EPS 66c, consensus 59c 10/26/20 Otis Worldwide raises FY20 adj. EPS view to $2.42 from $2.20-$2.30 10/26/20 Otis Worldwide reports Q3 adj. EPS 69c, consensus 56c OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) 02/01/21 Fly Intel: Pre-market Movers 10/26/20 Fly Intel: Pre-market Movers 03/04/21 Otis Worldwide - OTIS
Hot Stocks	Anghami to list on Nasdaq New York via Vistas Media Acquisition Company merger » 07:28 03/03/21 03/03 07:28 03/03/21 07:28 VMAC Vistas Media Acquisition Company $10.25 / +0.05 (+0.49%) Anghami, a music… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

OPTN
Today at 08:00

Optinose - OPTN Conference Calls
BQ
Today at 08:00

Boqii - BQ Conference Calls
ISEE
Today at 08:00

Iveric bio - ISEE Conference Calls
TSHA
Today at 08:00

Taysha Gene Therapies - TSHA Conference Calls
Today at 08:15

ADP Employment Report: Private Payrolls M/M: February 2021 Government Event
TAST
Today at 08:30

Carrols Restaurant - TAST Conference Calls
PASG
Today at 08:30

Passage Bio - PASG Conference Calls
CECE
Today at 08:30

CECO Environmental - CECE Conference Calls
SBBP
Today at 08:30

Strongbridge Biopharma - SBBP Conference Calls
WEN
Today at 08:30

Wendy's - WEN Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer $9.14 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

Dow Jones Industrial Average: Pivot points

TODAY'S FREE FLY STORIES

Get Full Fly Access